AKRX News and Press, Akorn Inc. From 09/20/19

Gainers: Helios and Matheson Analytics ( OTCPK:HMNY ) +42% . McDermott International (NYSE: MDR ) +31% . Midatech Pharma plc (NASDAQ: MTP ) +30% . Stage Store (NYSE: SSI ) +26% . San Juan Basin Royalty Trust (NYSE: SJT ) +20% . Interlink Electronics ( OTCPK:LINK ) +20% . California ...

Shares of Akorn ( AKRX ) have fallen nearly 40% since I last wrote about the company in May. Although the operations of the business have performed in-line with expectations, uncertainty around Akorn’s capital structure as well as another FDA warning letter have weighed on market se...

Akorn Inc (NASDAQ:AKRX) has received FDA approval for a nasal spray aimed at treating allergies, boosting Akorn stock over 10%. Akorn is a leading specialty generic pharmaceutical company based in Amityville, New York that develops, manufactures, and markets generic and brande...

LAKE FOREST, Ill., Aug. 26, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it received a new Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for Azelastine H...

U.S. Senator Bernie Sanders (I-VT) and Representative Elijah Cummings (D-MD - 7th district) have launched an investigation targeting Teva Pharmaceutical Industries ( TEVA -8% ), Mylan N.V. ( MYL -7.8% ) and Heritage Pharmaceuticals for allegedly obstructing a Congressional inquiry into...

Akorn, Inc. (AKRX) Q2 2019 Earnings Conference Call August 01, 2019 9:00 AM ET Company Participants Jennifer Bowles - Senior Vice President of Strategy & Investor Relations Douglas Boothe - President & Chief Executive Officer Duane Portwood - Chief Financial Officer Co...

Akorn ( AKRX ) Q2 results : Revenues: $178.1M (-6.7%). More news on: Akorn, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...

Akorn (NASDAQ: AKRX ): Q2 Non-GAAP EPS of -$0.02 beats by $0.05 ; GAAP EPS of -$0.89 misses by $0.59 . More news on: Akorn, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

LAKE FOREST, Ill., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced its preliminary financial results for the second quarter of 2019. Second Quarter 2019 and Recent Business Highlights Net revenue was $...

LAKE FOREST, Ill., July 11, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release before market open on Thursday, August 1, 2019 outlining its second quarter 2019 financi...